Pulse Biosciences, Inc. PLSE
Institutional shares held
5.76 Million
29.4K
calls
24K
puts
Total value of holdings
$82.9M
$423K
calls
$345K
puts
Market Cap
$535M
37,125,900
Shares Out.
Institutional ownership
15.5%
# of Institutions
87
We take great care to ensure that the data presented and summarized in this overview for Pulse Biosciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PLSE
View all-
Black Rock Inc. New York, NY1.15MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$16 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC805KShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$6.76 Million0.0% of portfolio
-
State Street Corp Boston, MA422KShares$6.08 Million0.0% of portfolio
-
Griffin Asset Management, Inc.227KShares$3.27 Million0.46% of portfolio
-
Northern Trust Corp Chicago, IL193KShares$2.77 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA153KShares$2.2 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA102KShares$1.47 Million0.11% of portfolio
-
Ubs Group Ag76.9KShares$1.11 Million0.0% of portfolio
Latest Institutional Activity in PLSE
Top Purchases
Top Sells
About PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Insider Transactions at PLSE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,600
-9.6%
|
$82,800
$18.53 P/Share
|
|
Oct 02
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+8.76%
|
$4,600
$1.53 P/Share
|
|
Sep 19
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-0.92%
|
$7,200
$18.48 P/Share
|
|
Sep 19
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+0.91%
|
$400
$1.53 P/Share
|
|
Sep 18
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-31.6%
|
$360,000
$18.49 P/Share
|
|
Sep 18
2025
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+24.01%
|
$20,000
$1.53 P/Share
|
|
Sep 17
2025
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
181,534
+21.1%
|
$726,136
$4.0 P/Share
|
|
Sep 17
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
20,000
-14.0%
|
$320,000
$16.21 P/Share
|
|
Sep 16
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
25,000
-16.91%
|
$400,000
$16.28 P/Share
|
|
Sep 16
2025
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.46%
|
$100,000
$4.0 P/Share
|
|
Sep 15
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
25,000
-16.91%
|
$375,000
$15.77 P/Share
|
|
Sep 15
2025
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.46%
|
$100,000
$4.0 P/Share
|
|
Sep 12
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
25,000
-16.91%
|
$350,000
$14.32 P/Share
|
|
Sep 12
2025
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.46%
|
$100,000
$4.0 P/Share
|
|
Sep 11
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
25,000
-16.91%
|
$350,000
$14.78 P/Share
|
|
Sep 11
2025
|
Darrin Uecker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.46%
|
$100,000
$4.0 P/Share
|
|
Sep 10
2025
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
34,659
+0.07%
|
$485,226
$14.66 P/Share
|
|
Jun 13
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
15,000
-10.88%
|
$225,000
$15.98 P/Share
|
|
Jun 12
2025
|
Darrin Uecker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
15,000
-9.81%
|
$240,000
$16.4 P/Share
|
|
Feb 03
2025
|
Maky Zanganeh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
30,121
+3.99%
|
$331,331
$11.0 P/Share
|
Last 12 Months Summary
Buy / Acquisition
5.76M
Shares
From
5
Insiders
| Open market or private purchase | 89.9K shares |
|---|---|
| Exercise of in-the-money or at-the-money derivatives securities | 5.37M shares |
| Exercise of conversion of derivative security | 307K shares |
Sell / Disposition
175K
Shares
From
2
Insiders
| Open market or private sale | 175K shares |
|---|